Wuhan Keqian Biology Co.,Ltd (688526.SS) SHH

Currency In CNY

AD

Valuation

Market Cap7.05B
Enterprise Value6.87B
P/E Ratio15.27
PEG Ratio-4.43
Price/Sales Ratio6.42
Price/Book Ratio1.39
Enterprise/Revenue6.21
Enterprise/EBITDA10.97

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.42
Operating Margin0.44
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.09

Income Statement

Revenue950.29M
Revenue/Share2
Gross Profit950.29M
EBITDA585.07M
Net Income415.6M
Diluted EPS0.9

Balance Sheet

Total Cash1.88B
Total Cash/Share4.03
Total Debt6.34M
Total Debt/Equity0
Current Ratio7.42
Book Value Per Share9.25

Price History

52-Week Change-20.9
52-Week High20.39
52-Week Low11.65
Moving Average 50 Days13.27
Moving Average 200 Days15.3

Statistics

Average Volume1.51M
Shares Outstanding466.13M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.64
Trailing Annual Dividend Yield4.99
Payout Ratio0.51
Last Split FactorN/A
Last Split DateN/A
AD